Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients
Radiation Dermatitis
About this trial
This is an interventional prevention trial for Radiation Dermatitis focused on measuring Nigella sativa, Black seed, Baraka, Radiation induced dermatitis, Breast cancer
Eligibility Criteria
Inclusion Criteria: Histologically confirmed invasive, early stage breast carcinoma scheduled for adjuvant radiotherapy. Women aged ≥18 years. Exclusion Criteria: Prior exposure to radiotherapy Patients with generalized skin disorder Patients who failed to sign the written consent
Sites / Locations
- Ain Shams University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Group I (control)
Group II (Topical intervention)
Group III (Oral intervention)
Patients will not receive any prophylactic intervention, as there is no standard of care for prophylaxis to the radiation induced dermatitis (RID).
Patients will receive Imtenan ® N. sativa oil apply 1.5 mls; twice daily; not sooner than 2 hours before and after radiation therapy; from day 1 of radiation therapy till the end.
Patients will receive Baraka ® N. sativa gelatin capsules; 40-80 mg/Kg/day; from day 1 of radiation therapy till the end